Vascular endothelial growth factor g1612a (rs10434) gene polymorphism and neuropsychiatric manifestations in systemic lupus erythematosus patients

13Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aim: To investigate the relation between vascular endothelial growth factor (VEGF) genepolymorphism in systemic lupus erythematosus (SLE) patients and lupus related neuropsy-chiatric manifestations. Patients and methods: Sixty adult SLE patients recruited from the Rheumatology and Neurol-ogy departments of Cairo University hospitals were classified into two groups; Group A: 30patients with neuropsychiatric manifestations (NPSLE) and Group B: 30 patients without. For both groups the SNP G1612A (rs10434) of the VEGF gene was genotyped by real timepolymerase chain reaction (RT-PCR).Results: Statistically significant difference was found in genotype and allele frequenciesbetween both groups (AA [70% vs 13.3%, p < 0.001] and GG [10% vs 66.7%, p < 0.001]).Conclusion: Polymorphism in the gene coding for VEGF may be associated with increasedincidence of neuropsychiatric lupus in SLE patients.

Cite

CITATION STYLE

APA

Taha, S., Gamal, S. M., Nabil, M., Naeem, N., Labib, D., Siam, I., & Gheita, T. A. (2017). Vascular endothelial growth factor g1612a (rs10434) gene polymorphism and neuropsychiatric manifestations in systemic lupus erythematosus patients. Revista Brasileira de Reumatologia, 57(2), 149–153. https://doi.org/10.1016/j.rbre.2016.11.007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free